06:46 AM EDT, 04/24/2024 (MT Newswires) -- Thermo Fisher Scientific ( TMO ) reported fiscal Q1 adjusted earnings Wednesday of $5.11 per diluted share, up from $5.03 a year earlier.

Analysts polled by Capital IQ expected $4.71.

Revenue for the quarter ended March 30 was $10.34 billion, down from $10.71 billion a year earlier.

Analysts surveyed by Capital IQ expected $10.18 billion.

The life sciences company said it now expects fiscal 2024 adjusted EPS of $21.14 to $22.02, compared with its prior guidance of $20.95 to $22.00. Analysts polled by Capital IQ are looking for $21.54.

Revenue for the current fiscal year is now projected to be $42.3 billion to $43.3 billion, compared with $42.1 billion to $43.3 billion previously, the company said. Analysts polled by Capital IQ expect $42.99 billion.

Shares of the company were up more than 2% in recent Wednesday premarket activity.

Price: 595.00, Change: +20.41, Percent Change: +3.55